Evidence map›Paper›PMID 41356357›Full record

ArticleResearch square2025

Two

Kim Chi Vo, Riëtte van Biljon, Gigliola Zanghi, Bryan Zavala-Martinez, William Betz, Ashley M Vaughan, Heather J Painter, Stefan H I Kappe

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Kim Chi VoCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Riëtte van BiljonDivision of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.ORCID https://orcid.org/0000-0002-1710-0441
Gigliola ZanghiCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-9656-9642
Bryan Zavala-MartinezDivision of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
William BetzCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Ashley M VaughanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID https://orcid.org/0000-0001-5815-756X
Heather J PainterDivision of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.ORCID https://orcid.org/0000-0003-0264-4689
Stefan H I KappeCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.ORCID https://orcid.org/0000-0003-1540-1731

Funding

Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoitesR01AI172824 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefan HI Kappe · 2023 to 2026
$3.2M
NIAID NIH HHS R01 AI172824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41356357
PMCPMC12676445

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.